Clinical Trial Update: Study of ARO-HIF2 in Patients With Advanced Clear Cell Renal Cell Carcinoma [Phase 1]

View source ↗

Summary

The document is a Clinical Trial Update reporting a Phase 1 study of ARO-HIF2 in advanced clear cell renal cell carcinoma, with the trial status listed as COMPL…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma

Drugs mentioned

• ARO-HIF2

Snippet

Sponsor: Arrowhead Pharmaceuticals | Conditions: Clear Cell Renal Cell Carcinoma | Phase 1 | Status: COMPLETED